SPIRONOLACTONE — CMP DEV LLC, approved 2023-08-24 (NDA209478).
96,567 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.